Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 57
Filter
1.
New ESMO scale ranks mutations as cancer medicine targets.
Fricker, Janet.
Lancet Oncol ; 19(10): e513, 2018 10.
Article in English | MEDLINE | ID: mdl-30177495

Subject(s)
Antineoplastic Agents/therapeutic use , Biomarkers, Tumor/genetics , Genomics/methods , Molecular Targeted Therapy/methods , Mutation , Neoplasms/drug therapy , Neoplasms/genetics , Precision Medicine/methods , Animals , Clinical Decision-Making , DNA Mutational Analysis , Genetic Predisposition to Disease , Humans , Neoplasms/pathology , Phenotype , Predictive Value of Tests
2.
Clinical News.
Moore, Mackenzie; Fricker, Janet; Leigh, Roland; Brahmania, Mayur; van Hazel, Guy.
Br J Hosp Med (Lond) ; 78(8): 428-431, 2017 Aug 02.
Article in English | MEDLINE | ID: mdl-28783407
3.
Clinical News.
Fricker, Janet; Moore, Mackenzie; Bennett, Simon J; Mallamaci, Francesca; Lyon, Sue; Fizazi, Karim; Fricker, Janet.
Br J Hosp Med (Lond) ; 78(7): 368-371, 2017 Jul 02.
Article in English | MEDLINE | ID: mdl-28692364
4.
European Association for the Study of the Liver: International Liver Congress 2017 Meeting.
Fricker, Janet.
Lancet Oncol ; 18(6): 713, 2017 06.
Article in English | MEDLINE | ID: mdl-28457711
5.
Clinical News.
Fricker, Janet; Lyon, Sue; Mayor, Susan.
Br J Hosp Med (Lond) ; 78(5): 248-251, 2017 May 02.
Article in English | MEDLINE | ID: mdl-28489433
6.
Thomas Starzl.
Fricker, Janet.
BMJ ; 357: j1806, 2017 04 11.
Article in English | MEDLINE | ID: mdl-28400419

Subject(s)
Allergy and Immunology/history , Heart Transplantation/history , Liver Transplantation/history , History, 20th Century , Humans , United States
7.
New NICE criteria for drug access.
Fricker, Janet.
Lancet Oncol ; 18(5): 576, 2017 05.
Article in English | MEDLINE | ID: mdl-28343973

Subject(s)
Antineoplastic Agents/economics , Antineoplastic Agents/therapeutic use , Drug Costs , Drug Industry/economics , Health Policy/economics , Health Services Accessibility/economics , State Medicine/economics , Cost-Benefit Analysis , Drug Costs/legislation & jurisprudence , Drug Industry/legislation & jurisprudence , England , Government Regulation , Health Policy/legislation & jurisprudence , Health Services Accessibility/legislation & jurisprudence , Humans , Policy Making , State Medicine/legislation & jurisprudence
8.
Umberto Veronesi.
Fricker, Janet.
BMJ ; 355: i6765, 2016 Dec 22.
Article in English | MEDLINE | ID: mdl-28007705

Subject(s)
General Surgery/history , Breast Neoplasms/surgery , History, 20th Century , History, 21st Century , Intraoperative Care/history , Mastectomy, Segmental/history , Radiotherapy, Adjuvant/history , Sentinel Lymph Node Biopsy/history
9.
Study estimates economic returns from UK cancer research.
Fricker, Janet.
Lancet Oncol ; 15(8): e314, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25121183

Subject(s)
Biomedical Research/economics , Neoplasms/economics , Humans , Quality-Adjusted Life Years , United Kingdom
10.
Heart Failure Congress 2012 promotes integration of pharmacology and technology.
Fricker, Janet.
Eur Heart J ; 33(14): 1705-6, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22977915

Subject(s)
Heart Failure/therapy , Congresses as Topic , Exercise Therapy , Heart-Assist Devices , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
11.
Webinars: the future of online medical education?
Fricker, Janet.
Eur Heart J ; 33(7): 807, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22586711

Subject(s)
Cardiology/education , Education, Medical/methods , Internet , Europe , Teaching/methods
12.
Five studies from HOT LINE I, European Society of Cardiology Congress 2011, Paris.
Fricker, Janet.
Eur Heart J ; 32(21): 2595-7, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22167848

Subject(s)
Cardiology , Congresses as Topic , Paris
13.
HOT LINE II from ESC Congress 2011, Paris.
Fricker, Janet.
Eur Heart J ; 32(21): 2598-600, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22167850

Subject(s)
Cardiology , Congresses as Topic , Paris
14.
HOT LINE III from ESC Congress 2011, Paris.
Fricker, Janet.
Eur Heart J ; 32(21): 2600-2, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22167849

Subject(s)
Cardiology , Congresses as Topic , Paris
15.
UK's adopts systematic approach to personalised cancer medicine.
Fricker, Janet.
Mol Oncol ; 5(3): 217-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21774109

Subject(s)
Neoplasms/therapy , Precision Medicine/methods , Female , Genetic Testing , Humans , Molecular Targeted Therapy/economics , Neoplasms/economics , Neoplasms/genetics , Precision Medicine/economics , United Kingdom
16.
Clinical trial update II: Jupiter trial, rosuvastatin has greater efficacy in elderly populations.
Fricker, Janet.
Eur Heart J ; 30(23): 2821, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19972644

Subject(s)
Cardiovascular Diseases/prevention & control , Fluorobenzenes/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Pyrimidines/therapeutic use , Sulfonamides/therapeutic use , Aged , Aged, 80 and over , Female , Humans , Male , Randomized Controlled Trials as Topic , Rosuvastatin Calcium
17.
HOTLINE III, MADIT, cardiac resynchronization reduces risk of heart failure in NYHA class I and II.
Fricker, Janet.
Eur Heart J ; 30(21): 2544-5, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19891083
18.
Putting Europe on the scientific map.
Fricker, Janet.
Mol Oncol ; 3(5-6): 368-8, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19902566

Subject(s)
Research Personnel , Research , Europe , Humans , Research/economics , Workforce
19.
Profile: Professor John Mendelsohn.
Fricker, Janet.
Mol Oncol ; 3(2): 88-90, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19383371

Subject(s)
Biomedical Research , Neoplasms , Biomedical Research/history , Biomedical Research/methods , History, 20th Century , History, 21st Century , Humans , Molecular Biology/history , Molecular Biology/methods , Neoplasms/etiology , Neoplasms/history , Neoplasms/pathology
20.
An interview with Alexander Eggermont.
Fricker, Janet; Eggermont, Alexander.
Mol Oncol ; 3(3): 188-91, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19398220

Subject(s)
Medical Oncology , Neoplasms/therapy , Societies, Medical , Europe , Humans , Medical Oncology/methods , Medical Oncology/trends
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL